08:58 EDT Rapt Therapeutics files $450M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RAPT:
- RAPT Therapeutics Reports Second Quarter 2023 Financial Results
- UPS downgraded, Eli Lilly upgraded: Wall Street’s top analyst calls
- Rapt Therapeutics initiated with a Buy at Stifel
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Rapt Therapeutics could be valued at ~$7B, says Capital One